What Happens to Your Biopsy Sample in the Lab — A Step-by-Step Explanation

The Journey Most Patients Never See — But That Determines Their Diagnosis

When a biopsy is taken and the procedure ends, most patients focus on the wait for results — the days between the needle leaving their body and the phone call or appointment that brings an answer. What happens in between is invisible to them. The sample disappears into a laboratory, and several days later a report emerges. To a patient awaiting a diagnosis, those intervening days can feel opaque and anxiety-inducing.

Understanding what actually happens to a biopsy sample inside a histopathology laboratory demystifies the process, explains why results take the time they do, and gives patients a genuine appreciation of the scientific rigour behind the diagnosis they ultimately receive. At Alnoor Diagnostic Centre in Shadman, Lahore, every biopsy sample passes through this precise, carefully controlled process before our pathologists produce the reports that clinicians across the city depend on.

---

Step One — Receipt and Registration

The process begins the moment the sample arrives at the laboratory. Every specimen that enters a histopathology laboratory must be registered with complete, verified identification before anything else happens. The specimen container is matched against the request form — patient name, identification number, date of collection, clinical details, the site from which the biopsy was taken, and the clinical question the examining pathologist needs to answer are all confirmed and recorded.

This registration step is not administrative formality — it is a patient safety measure of fundamental importance. A sample misidentified at this stage could result in another patient’s diagnosis being applied to the wrong person. Every histopathology laboratory maintains strict specimen identification protocols precisely because the consequences of identification error in pathology are among the most serious in all of medicine.

Once registered, the specimen is assigned a unique laboratory accession number that follows it through every subsequent step and links every result, slide, and report to that specific patient and that specific specimen.

---

Step Two — Fixation

The specimen arrives immersed in formalin — typically ten percent neutral buffered formalin — the chemical fixative that was added to the container at the point of collection. Fixation is arguably the most critical variable in the entire histopathological process. Formalin penetrates tissue and chemically cross-links proteins, halting all biological processes and preserving the cellular architecture in the precise state it was at the moment of collection.

Adequate fixation requires time — the formalin must penetrate to the centre of the specimen. Thin needle biopsy cores may be adequately fixed within a few hours. Larger surgical specimens — a resected tumour or excised organ — require twelve to twenty-four hours or longer to fix completely. Inadequately fixed tissue undergoes autolysis — the cell’s own enzymes begin digesting the tissue from within — producing artefacts that obscure microscopic detail and compromise diagnostic accuracy. Overfixation can also distort tissue and impair subsequent immunohistochemical staining.

---

Step Three — Gross Examination

Before any microscopic processing begins, the pathologist or a trained pathology assistant examines the fixed specimen macroscopically — with the naked eye and a ruler — in a procedure called grossing or cut-up. This examination is itself diagnostically informative and requires both anatomical knowledge and pathological expertise.

For a small core needle biopsy, grossing is relatively brief — the cores are measured, their colour and consistency noted, and they are placed entirely into tissue cassettes for processing. For a larger surgical specimen — a resected bowel segment, a mastectomy, or a liver resection — grossing is a detailed and systematic examination that may take thirty minutes to an hour or longer.

The gross examination of a surgical specimen involves measuring the specimen in all dimensions, describing its external surface, identifying anatomical landmarks, opening the specimen to expose its cut surface, identifying any gross abnormalities including tumours — measuring their size, describing their colour, consistency, and borders, and determining their relationship to the specimen margins. The margins are inked with different coloured inks before sectioning so that the pathologist can later determine at the microscopic level whether tumour cells are present at the cut edge — the resection margin.

Representative sections are selected for histological processing — sections from the tumour at its widest diameter, sections from the junction of tumour and normal tissue, sections from each surgical margin, sections from any lymph nodes present, and sections from normal-appearing areas of the specimen. Each section is placed into a labelled tissue cassette.

---

Step Four — Tissue Processing

The tissue cassettes containing selected sections proceed through automated tissue processing — a sequence of chemical steps performed by a tissue processing machine that typically runs overnight. This sequence has a specific purpose at each stage.

Dehydration removes all water from the tissue through a series of graded alcohols of increasing concentration. Tissue contains predominantly water, which is not miscible with the paraffin wax that will eventually infiltrate and support it — all water must be removed first.

Clearing replaces the alcohol with a solvent — typically xylene — that is miscible with both alcohol and paraffin wax, bridging the transition between the two.

Wax infiltration immerses the tissue in molten paraffin wax under heat and vacuum, replacing the clearing agent entirely with wax that penetrates every space within the tissue. The tissue is now permeated with wax that will solidify to provide the rigid support needed for thin sectioning.

The entire processing cycle typically takes eight to twelve hours — which is why tissue collected and delivered to the laboratory in the afternoon will typically be processed overnight, ready for the next stage the following morning.

---

Step Five — Embedding

After processing, the wax-infiltrated tissue must be embedded into a paraffin block for sectioning. Each tissue section is removed from its cassette and placed face-down in a metal mould. The pathologist or histotechnician ensures the tissue is correctly oriented — the face of the section that will be cut must be flat and parallel to the base of the mould. Molten paraffin wax is poured to fill the mould around the tissue, and the filled mould is placed on a cold plate to solidify rapidly.

The result is a paraffin block — a solid block of wax containing the tissue section embedded within it, supported on all sides by the rigid wax matrix. These blocks are labelled with the accession number and cassette identifier and stored permanently in the laboratory archive — they can be retrieved years later if additional sections or stains are needed.

---

Step Six — Sectioning

The paraffin block is mounted on a precision cutting instrument called a microtome. A sharp blade advances in precise increments against the face of the block, shaving sections of tissue at a thickness of three to five micrometres — approximately one-twentieth of a human hair’s diameter. At this thickness, cells are rendered translucent and their internal structures visible under the microscope.

Each section, still attached to paraffin wax, is floated onto a warm water bath — the water temperature is precisely controlled to allow the section to spread and flatten without melting the wax. A glass microscope slide is used to pick up the floating section, which adheres to the slide surface as the water is drained away. The slides are placed in an oven to dry and adhere firmly, completing the sectioning process.

Multiple sections are cut from each block — typically three to five — to provide sections for routine staining, additional special stains, immunohistochemistry, and reserve sections if further studies are needed.

---

Step Seven — Staining

Unstained tissue sections on glass slides are colourless and structurally invisible under the microscope — the cellular architecture cannot be resolved without differential staining that highlights different tissue components with contrasting colours.

The universal primary stain in histopathology is haematoxylin and eosin — H&E. Slides pass through an automated staining machine that applies haematoxylin — which binds to nucleic acids in cell nuclei, staining them blue-purple — and eosin — which binds to proteins in the cytoplasm and extracellular material, staining them pink. The resulting slide shows the tissue in vivid blue and pink contrast that reveals the cellular architecture, nuclear morphology, and tissue organisation the pathologist reads to make the diagnosis.

After staining, a thin glass coverslip is mounted over the stained section using a mounting medium, protecting the section permanently and providing the optical clarity needed for microscopy.

---

Step Eight — Special Stains and Immunohistochemistry

When the H&E-stained slides reveal findings that require additional characterisation, special stains or immunohistochemical studies are applied to additional sections from the same paraffin block.

Special stains use chemical reactions to highlight specific tissue components not adequately visualised on H&E. Periodic acid-Schiff stain identifies fungal organisms and glycogen. Ziehl-Neelsen stain reveals acid-fast mycobacteria in tuberculosis cases. Masson’s trichrome quantifies collagen fibrosis in liver biopsies. Congo red identifies amyloid deposits, producing the characteristic apple-green birefringence under polarised light that confirms amyloidosis.

Immunohistochemistry — IHC — applies specific antibodies to additional tissue sections. Each antibody binds to a specific protein target within cells wherever that protein is expressed. A detection system then produces a coloured reaction product — typically brown — at the site of antibody binding, making positive cells visible under the microscope.

IHC provides critical diagnostic and prognostic information in oncology. It identifies the tissue of origin of a metastatic tumour whose primary site is unknown — different tumour types express characteristic panels of proteins that pathologists use to trace the cancer to its source. It classifies lymphomas — different lymphoma subtypes express different combinations of lymphoid markers that determine treatment. It identifies hormone receptor status in breast cancer — oestrogen receptor, progesterone receptor, and HER2 — that determines eligibility for hormonal therapy and targeted biological agents. It detects specific infectious agents within tissue — HPV in cervical biopsies, H. pylori in gastric biopsies — directly from the tissue section without additional laboratory tests.

IHC studies require additional processing time — typically one to two working days — which is why final reports on complex cases with immunohistochemical workup take longer than straightforward biopsies requiring only H&E examination.

---

Step Nine — Pathologist Examination and Reporting

With stained slides in hand, the pathologist examines the tissue under the microscope — assessing architectural organisation at low magnification, then examining individual cells at high magnification. The pathologist reads the microscopic landscape: the pattern of tissue disruption, the characteristics of individual cells including nuclear size, chromatin distribution, nucleolar prominence, and mitotic activity, the nature of any inflammatory infiltrate, the presence of invasion into surrounding structures, and the relationship of any abnormality to the specimen margins.

For a malignant diagnosis, the report documents the tumour type and subtype, histological grade, tumour size, lymphovascular invasion status, perineural invasion, margin status, and the results of all immunohistochemical studies performed. For a benign diagnosis, the specific pathological entity is named with any clinically relevant features described. For an inconclusive result, the pathologist documents what has been excluded, what cannot be excluded, and recommends the next diagnostic step.

The completed report is issued to the referring clinician — typically within five to seven working days for standard biopsies, with complex cases requiring immunohistochemical workup taking seven to ten days.

---

Histopathology at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, every biopsy sample is processed through this complete, rigorous sequence by our experienced histotechnicians and examined by our trained pathologists with the thoroughness that accurate diagnosis demands. Our laboratory maintains the equipment, protocols, and quality standards that ensure every result is reliable, reproducible, and clinically meaningful.

How a Biopsy Works — From Sample Collection to Final Diagnosis

The Investigation That Provides the Definitive Answer

When a doctor recommends a biopsy, patients often feel a surge of anxiety — not necessarily because of what the word implies, but because of uncertainty about what the procedure actually involves. Will it hurt? How long will it take? When will the results come? What will happen next? These are entirely reasonable questions, and clear answers to them transform a frightening unknown into a manageable, well-understood clinical process.

A biopsy is the removal of a small sample of tissue from the body for laboratory examination. It is the investigation that provides the most definitive answers in medicine — confirming or excluding cancer, identifying the specific type of disease affecting an organ, determining whether a condition is responding to treatment, and providing the biological information that guides every subsequent clinical decision. At Alnoor Diagnostic Centre in Shadman, Lahore, we perform biopsies under imaging guidance and provide the histopathological examination that transforms a tissue sample into a clinically actionable diagnosis.

---

Why a Biopsy Is Recommended

A biopsy is recommended when clinical examination, blood tests, and imaging have identified an abnormality but cannot provide the definitive diagnosis that treatment planning requires. An ultrasound may show a liver mass but cannot confirm whether it is a benign cyst, a haemangioma, a primary liver tumour, or a metastasis from another cancer. A mammogram may show a suspicious area in the breast but cannot determine whether it is benign fibrocystic change or malignant carcinoma. An enlarged lymph node may be reactive from infection or represent lymphoma — and only tissue examination distinguishes between them.

The biopsy provides the tissue that the pathologist examines under the microscope, where the cellular architecture reveals the diagnosis that no other investigation can provide with equivalent certainty.

---

Types of Biopsy — Matched to the Clinical Situation

Different biopsy techniques are used depending on where the target tissue is located, how accessible it is, and how much tissue is needed for adequate histopathological examination.

Core needle biopsy is the most commonly performed image-guided biopsy technique at Alnoor Diagnostic Centre. A hollow biopsy needle is advanced into the target lesion under real-time imaging guidance — ultrasound for superficial lesions in the breast, liver, lymph nodes, and soft tissue, or CT guidance for deeper lesions in the lung, retroperitoneum, and bone. The needle contains a spring-loaded cutting mechanism that fires rapidly to extract a cylindrical core of tissue — typically one to two centimetres long and one to two millimetres in diameter. Multiple cores are taken from different areas of the lesion to ensure representative sampling. The procedure takes fifteen to thirty minutes and is performed under local anaesthesia.

Fine needle aspiration cytology — FNAC uses a thinner needle attached to a syringe to aspirate cells — rather than a tissue core — from a lesion. The aspirated material is smeared onto glass slides and examined cytologically — individual cells and cell clusters are assessed rather than intact tissue architecture. FNAC is faster and less invasive than core needle biopsy but provides less tissue information. It is most appropriate for superficial lesions where cytological examination is sufficient for diagnosis — thyroid nodules, salivary gland lesions, and superficial lymph nodes are common FNAC targets.

Endoscopic biopsy is performed during gastroscopy, colonoscopy, bronchoscopy, or cystoscopy when mucosal abnormalities in the gastrointestinal, respiratory, or urological tracts require tissue sampling. Small biopsy forceps passed through the endoscope channel grasp and remove small mucosal fragments under direct visual guidance.

Surgical excision biopsy removes the entire lesion rather than a representative sample — serving as both diagnostic and therapeutic. This approach is used when the lesion is small enough for complete removal, when the tissue architecture of the whole lesion is needed for diagnosis, or when the lesion cannot be adequately sampled by needle techniques.

---

What Happens During an Image-Guided Core Needle Biopsy

Understanding the step-by-step process of a core needle biopsy removes the uncertainty that makes patients anxious before the procedure.

Arrival and preparation — When you arrive at Alnoor Diagnostic Centre, the team confirms your identity and reviews your clinical history, relevant imaging, and any blood tests including clotting function. You will be asked about any blood-thinning medications — anticoagulants must frequently be paused before biopsy, and your referring doctor will have provided specific instructions. An intravenous line may be placed if sedation is planned.

Positioning — You are positioned on the procedure table in the orientation that gives the radiologist optimal access to the target lesion while maintaining your comfort. For a breast biopsy you may lie on your back or side. For a liver or kidney biopsy you typically lie on your side or prone. The skin over the biopsy site is cleaned with antiseptic solution and sterile drapes are applied.

Imaging guidance and planning — The radiologist uses ultrasound or CT imaging to identify the target lesion and plan the needle path — selecting the approach that reaches the lesion most directly while avoiding critical structures including major blood vessels, bile ducts, and bowel.

Local anaesthesia — Local anaesthetic is injected into the skin and the deeper tissues along the planned needle path. This produces a brief stinging sensation that resolves within seconds. Once the anaesthetic has taken effect — typically two to three minutes — the deeper tissues are numb and the procedure itself causes no sharp pain. Patients may feel pressure as the needle is advanced, and a brief clicking sound and sensation when the biopsy device fires — but not pain.

Core sampling — The biopsy needle is advanced under continuous imaging guidance to the edge of the target lesion. The position is confirmed on imaging before the biopsy device is fired. The spring-loaded mechanism fires in a fraction of a second, cutting and capturing a core of tissue. The needle is withdrawn and the core sample is placed in formalin solution. Typically three to five cores are taken from different areas of the lesion to ensure comprehensive sampling. Each firing takes only a moment and the entire sampling phase lasts only a few minutes.

Post-procedure care — Firm pressure is applied to the biopsy site for several minutes to minimise bleeding. In most cases this is sufficient haemostasis. A small sterile dressing is applied. You are observed for fifteen to thirty minutes before discharge in most cases. Most patients feel comfortable enough to travel home independently for superficial biopsies, though having a companion is always advisable. Post-procedure instructions cover activity restrictions — typically avoiding strenuous activity for twenty-four to forty-eight hours — and describe the symptoms that would require urgent medical attention, including significant swelling, haemorrhage, fever, or severe pain.

---

What Happens to the Tissue Sample

The biopsy cores are transported to the histopathology laboratory immersed in formalin — the fixative that halts biological processes and preserves the tissue architecture at the cellular level. In the laboratory, the tissue undergoes the standardised processing sequence — fixation, embedding in paraffin wax, sectioning on a microtome, staining with haematoxylin and eosin, and any additional special stains or immunohistochemical studies indicated by the preliminary microscopic findings.

The pathologist examines the stained slides systematically — assessing tissue architecture, cellular characteristics, the nature of any inflammatory response, and any features of malignancy including abnormal nuclear morphology, increased mitotic activity, and invasion of surrounding structures. When additional immunohistochemical studies are needed — to determine the type of malignancy, identify specific markers that guide treatment, or confirm a specific diagnosis — additional sections from the paraffin block are stained with the appropriate antibodies. These studies add one to two days to the reporting timeline.

---

What the Biopsy Report Contains

The histopathology report provides the clinical team with the definitive tissue diagnosis. For a malignant lesion it specifies the tumour type and subtype, the grade reflecting cellular differentiation and aggressiveness, and the results of immunohistochemical studies that identify prognostic markers and treatment targets. For a benign lesion it provides a specific diagnosis — confirming whether the tissue is normal, shows reactive changes, inflammation, or a specific benign condition. For an inconclusive result it recommends the next diagnostic step.

The report is issued to the referring clinician who integrates the pathological diagnosis with the clinical and imaging findings to formulate the complete diagnosis and treatment plan. Most standard biopsies are reported within five to seven working days.

---

Image-Guided Biopsy and Histopathology at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, our interventional radiology team performs image-guided biopsies under ultrasound and CT guidance with the precision and patient care that this important procedure demands. Our histopathology laboratory provides expert tissue processing and pathological examination with the thoroughness and clinical relevance that every patient’s diagnosis deserves.

What Is Thalassaemia and How Is It Diagnosed Through HPLC Testing?

A Condition That Affects Millions of Pakistanis — Yet Remains Widely Misunderstood

Thalassaemia is one of the most common inherited blood disorders in Pakistan. It affects hundreds of thousands of families across the country, and Pakistan has one of the highest carrier rates of beta-thalassaemia in the world — estimates suggest that approximately five to eight percent of the Pakistani population carries the thalassaemia trait without knowing it. In Lahore alone, new cases of thalassaemia major are diagnosed every week in children whose parents had no idea they were both carriers before their child was born.

Despite its prevalence, thalassaemia remains poorly understood by the general public. Many patients and families receive a diagnosis without a clear explanation of what the condition actually involves, why it causes the problems it does, or what the difference is between being a carrier and having the disease. This guide provides that explanation — and explains why HPLC testing at Alnoor Diagnostic Centre in Shadman, Lahore is the most accurate and reliable method of diagnosis currently available.

---

What Is Thalassaemia — The Biology in Plain Language

Thalassaemia is an inherited disorder of haemoglobin — the protein inside red blood cells that carries oxygen. Normal adult haemoglobin is composed of two alpha-globin chains and two beta-globin chains bound together around an iron-containing haem group. This structure is precisely engineered to bind oxygen efficiently in the lungs and release it in the tissues.

Thalassaemia results from genetic mutations that reduce or eliminate the production of one of these globin chain types. When insufficient globin chains are produced, haemoglobin assembly is disrupted. The unpaired excess chains are unstable — they precipitate within developing red blood cells, damaging them and causing their premature destruction. The result is a chronic haemolytic anaemia whose severity depends entirely on how many of the relevant genes are affected.

Beta-thalassaemia involves mutations affecting the beta-globin genes on chromosome 11. Alpha-thalassaemia involves deletions or mutations affecting the alpha-globin genes on chromosome 16. Beta-thalassaemia is by far the more clinically significant form in Pakistan and is the primary focus of thalassaemia diagnosis and prevention programmes across the country.

---

The Spectrum of Beta-Thalassaemia — Trait, Intermedia, and Major

Understanding that beta-thalassaemia is not a single condition but a spectrum of severity ranging from a clinically silent carrier state to a life-threatening transfusion-dependent disease is essential for patients and families to grasp.

Beta-thalassaemia trait — also called beta-thalassaemia minor — occurs when one of the two beta-globin genes carries a thalassaemia mutation while the other remains normal. Carriers produce sufficient haemoglobin for normal or near-normal red cell function. They typically have mild anaemia with a characteristically low MCV and low MCH — small, pale red cells — that is frequently mistaken for iron deficiency anaemia and treated with iron supplements that have no benefit. Carriers are healthy individuals who may be unaware of their carrier status throughout their lives unless specifically tested.

The critical clinical importance of carrier status is reproductive. When two carriers of beta-thalassaemia trait have children, each pregnancy carries a one in four chance of producing a child with beta-thalassaemia major — and a one in two chance of producing another carrier. Every couple where both partners are carriers faces this statistical reality with every pregnancy.

Beta-thalassaemia major — also called Cooley’s anaemia — occurs when both beta-globin genes carry thalassaemia mutations, completely or severely impairing beta-chain production. Affected children are born appearing normal but develop severe, life-threatening anaemia in the first months of life as foetal haemoglobin — which uses gamma chains rather than beta chains — is replaced by adult haemoglobin whose beta chains cannot be produced. Without treatment, children with thalassaemia major would not survive. With treatment — regular blood transfusions every three to four weeks and iron chelation therapy to manage the iron overload that accumulates from repeated transfusions — they can live into adulthood, though the treatment burden is enormous and lifelong.

Beta-thalassaemia intermedia falls between these two extremes — patients have significant anaemia and symptoms but can survive without regular transfusions, at least in the early years of the disease.

---

The Scale of the Problem in Pakistan

Pakistan has the second highest number of thalassaemia major children in the world. Approximately five thousand new thalassaemia major babies are born in Pakistan every year. The primary reason for this burden is the marriage of two carriers — often within extended family networks where the same thalassaemia mutations run through both sides of the family — without pre-marital or pre-pregnancy carrier screening.

The tragedy of each new thalassaemia major birth is that it is preventable. Identifying both parents as carriers before or early in pregnancy allows informed decision-making and, where appropriate, prenatal diagnosis. But identification requires accurate carrier testing — and this is where HPLC plays its essential role.

---

Why the Standard CBC Misses Thalassaemia Trait

The classic CBC finding in beta-thalassaemia trait is a microcytic, hypochromic anaemia with a low MCV, low MCH, and normal or elevated red cell count. This pattern is clinically indistinguishable from iron deficiency anaemia on the CBC alone — and iron deficiency is so prevalent in Pakistan that the thalassaemia carrier is almost invariably assumed to be iron deficient and prescribed iron supplements.

The fundamental difference is this — iron deficiency anaemia responds to iron supplementation and thalassaemia trait does not. A patient who has been given iron for months without improvement of their anaemia deserves thalassaemia testing. But waiting for treatment failure before testing means months of unnecessary medication and delayed diagnosis.

HPLC directly identifies the abnormal haemoglobin variants and quantifies haemoglobin fractions that distinguish thalassaemia from iron deficiency without ambiguity — making the diagnosis definitively at the time of testing rather than retrospectively after failed treatment.

---

What Is HPLC and How Does It Work?

HPLC stands for High Performance Liquid Chromatography. It is a laboratory analytical technique that separates and quantifies the different haemoglobin fractions present in a blood sample based on their individual physical and chemical properties.

In the HPLC analyser, a small sample of blood is injected into a column containing a specialised material through which a liquid solvent flows under high pressure. Different haemoglobin variants — HbA, HbA2, HbF, HbS, HbC, HbE, and others — have slightly different molecular charges and interact differently with the column material, causing them to travel through the column at different speeds. As each fraction elutes — exits the column — it passes through a detector that measures its concentration. The result is a chromatogram — a graph showing peaks corresponding to each haemoglobin fraction — with precise quantification of the percentage of each type present.

The entire analysis takes approximately six minutes per sample. The output is highly reproducible, operator-independent, and provides a permanent digital record of the chromatographic pattern.

---

What HPLC Reveals in Thalassaemia Diagnosis

Beta-thalassaemia trait — The hallmark of beta-thalassaemia minor on HPLC is an elevated HbA2 fraction — typically between 3.5 and 7.0 percent, compared to the normal range of 2.0 to 3.3 percent. This elevation occurs because when beta-chain production is reduced, the body compensates by producing relatively more delta chains — which combine with alpha chains to form HbA2. This characteristic and reliable elevation of HbA2 is the definitive diagnostic finding for beta-thalassaemia trait and is clearly and accurately quantified by HPLC.

Beta-thalassaemia major and intermedia — In more severe forms, HbA is severely reduced or absent, HbF — foetal haemoglobin — is markedly elevated as the body desperately maintains whatever haemoglobin production it can using gamma chains, and the overall haemoglobin profile is profoundly abnormal. The HPLC pattern in thalassaemia major is unmistakable.

Delta-beta thalassaemia — This variant produces a characteristic pattern with absent or reduced HbA2 alongside markedly elevated HbF, distinguishable from simple beta-thalassaemia trait on the HPLC chromatogram.

Haemoglobin E — HbE is the most common structural haemoglobin variant in South and Southeast Asia. When inherited together with a beta-thalassaemia mutation — a condition called HbE-beta thalassaemia — it produces significant disease. HPLC identifies and quantifies HbE precisely, which is critical because HbE-beta thalassaemia is clinically important in Pakistan’s population and was previously difficult to diagnose reliably.

Sickle cell disease and sickle cell trait — HbS — the abnormal haemoglobin of sickle cell disease — is detected and quantified by HPLC with high accuracy. While sickle cell disease is less prevalent than thalassaemia in Pakistan, it occurs and requires accurate identification for clinical management and genetic counselling.

Haemoglobin variants in general — HPLC detects and characterises a wide range of structural haemoglobin variants beyond those listed above, providing a comprehensive haemoglobinopathy screen from a single test.

---

When Should HPLC Testing Be Done?

Every individual with unexplained microcytic hypochromic anaemia that has not responded to iron supplementation should have HPLC testing. Every person with a family history of thalassaemia should be tested regardless of whether their CBC appears abnormal. Premarital and pre-pregnancy HPLC screening of both partners is the most important application of the test from a public health perspective — identifying carrier couples before pregnancy allows informed reproductive decision-making and is the foundation of thalassaemia prevention.

Pregnant women with microcytic anaemia should have HPLC performed urgently — if thalassaemia trait is confirmed, the partner must be tested immediately, and if both are carriers, prenatal diagnosis options must be discussed without delay. Children with severe unexplained anaemia in the first year of life require HPLC as part of the urgent diagnostic workup.

---

HPLC Testing at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, we provide HPLC haemoglobinopathy testing using modern automated analysers operated by experienced laboratory scientists. Our results are precise, reproducible, and reported with the clinical detail that haematologists, paediatricians, obstetricians, and genetic counsellors across the city depend on for accurate diagnosis and counselling.

Whether you are seeking testing for yourself, for premarital screening, during pregnancy, or for a child with unexplained anaemia, our team is here to provide the most accurate diagnosis available — promptly and professionally.

Complete Blood Count (CBC) — What Each Parameter Reveals About Your Health

The Most Informative Test in Medicine — And the Most Underappreciated

If there is one laboratory investigation that every clinician across Lahore orders more than any other, it is the complete blood count. It is requested for a patient with fatigue, a child with fever, a pregnant woman at her first antenatal visit, a cancer patient on chemotherapy, a surgical patient before an operation, and an elderly man with unexplained weight loss. It is among the first investigations ordered and among the last to be discontinued. Yet many patients who receive their CBC results look at a page of numbers and abbreviations and understand almost nothing about what those numbers mean for their health.

This guide explains every major parameter of the CBC in plain, accurate language — what it measures, what it means when it is normal, and what clinically significant abnormalities in each direction reveal about the body’s underlying condition. At Alnoor Diagnostic Centre in Shadman, Lahore, our haematology laboratory provides comprehensive CBC analysis with the accuracy and detail that clinicians across the city depend on for sound clinical decisions.

---

Haemoglobin — The Oxygen-Carrying Measurement

Haemoglobin is the iron-containing protein within red blood cells that binds oxygen in the lungs and releases it in the tissues. The haemoglobin concentration in the CBC reflects the blood’s total oxygen-carrying capacity and is the primary measurement used to diagnose and classify anaemia.

Normal haemoglobin ranges differ between men — typically 13.5 to 17.5 grams per decilitre — and women — 12.0 to 15.5 grams per decilitre — and are lower in children and pregnant women. A haemoglobin below the lower limit of normal for age and sex defines anaemia. Mild anaemia may produce only fatigue and reduced exercise tolerance. Moderate anaemia causes breathlessness, palpitations, and pallor. Severe anaemia — particularly when it develops acutely — can cause chest pain, heart failure, and haemodynamic compromise requiring emergency transfusion.

The haemoglobin alone does not identify the cause of anaemia — that requires interpretation alongside other CBC parameters, particularly the mean corpuscular volume and red cell distribution width, alongside clinical history and additional investigations.

A haemoglobin above the upper limit of normal — polycythaemia — raises the possibility of primary polycythaemia vera, a myeloproliferative disorder, or secondary polycythaemia from chronic hypoxia, dehydration, or erythropoietin-secreting tumours.

---

Haematocrit — The Proportion of Red Cells in Blood

The haematocrit — also called the packed cell volume — expresses red blood cells as a percentage of total blood volume. It moves in parallel with haemoglobin and is used interchangeably in many clinical contexts. A haematocrit of 45 percent means that 45 percent of the blood volume is occupied by red cells.

Haematocrit is particularly useful in assessing dehydration — where the percentage of red cells appears artificially elevated because plasma volume has decreased — and in monitoring patients receiving blood transfusions or erythropoiesis-stimulating agents for renal anaemia.

---

Red Blood Cell Count — The Number of Red Cells

The red blood cell count measures the total number of red cells per litre of blood. It generally parallels haemoglobin and haematocrit but diverges in thalassaemia — where patients have a large number of small, poorly haemoglobinised red cells, producing a normal or elevated red cell count alongside a low haemoglobin. This pattern — low haemoglobin with a high or normal red cell count — is a characteristic finding in beta-thalassaemia trait that the CBC identifies without any additional test.

---

Mean Corpuscular Volume — The Single Most Diagnostically Useful Red Cell Index

The mean corpuscular volume — MCV — measures the average size of red blood cells in femtolitres. It is arguably the single most diagnostically informative parameter in the CBC for classifying the cause of anaemia, dividing anaemias into three fundamental categories that direct the subsequent diagnostic workup.

A low MCV — below 80 femtolitres — indicates microcytic anaemia. The two most common causes in Lahore are iron deficiency anaemia and thalassaemia trait. Iron deficiency is by far the most prevalent cause of anaemia in Pakistan — driven by inadequate dietary intake, chronic blood loss from gastrointestinal sources, heavy menstrual bleeding, and the increased iron demands of pregnancy. Thalassaemia trait is also extremely common in Pakistan’s population. Distinguishing between these two causes requires additional investigations — serum ferritin for iron stores, and haemoglobin electrophoresis for thalassaemia — but the low MCV is what directs this investigation in the first place.

A normal MCV — 80 to 100 femtolitres — with anaemia indicates normocytic anaemia. This pattern occurs in anaemia of chronic disease — the anaemia associated with chronic infection, inflammatory conditions, kidney disease, and malignancy. It also occurs in early iron deficiency before red cells have fully shrunk, mixed deficiency states where microcytic and macrocytic causes coexist and average out to a normal MCV, and acute blood loss where new red cells being produced are of normal size.

A high MCV — above 100 femtolitres — indicates macrocytic anaemia. The most common causes are vitamin B12 deficiency and folate deficiency — both essential nutrients for normal DNA synthesis in developing red cells. When B12 or folate is deficient, red cells cannot divide normally and grow excessively large before being released into the circulation. Alcohol excess, liver disease, hypothyroidism, and certain medications including methotrexate, hydroxyurea, and some antiretrovirals also cause macrocytosis. The peripheral blood film in macrocytic anaemia from B12 or folate deficiency shows hypersegmented neutrophils — a specific finding that supports the diagnosis.

---

Mean Corpuscular Haemoglobin and MCHC — How Well Each Red Cell Is Filled

The mean corpuscular haemoglobin — MCH — measures the average amount of haemoglobin within each red cell. The mean corpuscular haemoglobin concentration — MCHC — measures the concentration of haemoglobin within the average red cell. Both are low in iron deficiency and thalassaemia, where red cells are poorly haemoglobinised and appear pale on the peripheral blood film — a characteristic called hypochromia.

An elevated MCHC above the normal range occurs in hereditary spherocytosis — a condition where abnormally shaped red cells are more densely packed with haemoglobin than normal — and serves as a diagnostic pointer toward this condition when found alongside anaemia and raised bilirubin.

---

Red Cell Distribution Width — Detecting Mixed Deficiencies and Early Deficiency

The red cell distribution width — RDW — measures the variability in size among red blood cells. A high RDW indicates that red cells are varying widely in size — a finding called anisocytosis. This occurs when the bone marrow is producing red cells of irregular sizes rather than the uniformly sized cells of a healthy marrow.

The RDW is particularly valuable for two clinical purposes. First, it distinguishes iron deficiency anaemia — where RDW is typically elevated because of the mixed population of old normal cells and new small iron-deficient cells — from thalassaemia trait, where the microcytic cells are more uniformly small and RDW is typically normal. Second, it identifies mixed deficiency states — patients deficient in both iron and B12 simultaneously, for example — where the MCV may appear falsely normal because the two opposing size changes cancel each other out, but the RDW is markedly elevated reflecting the mixed population of small and large cells.

---

White Blood Cell Count — The Immune System at a Glance

The total white blood cell count measures the combined number of all white cell types per litre of blood. Its most immediate clinical value is in identifying responses to infection and inflammation and in detecting haematological malignancy.

A markedly elevated white count — leucocytosis — most commonly reflects bacterial infection, in which the bone marrow accelerates neutrophil production in response to inflammatory signals. Physiological leucocytosis also occurs in pregnancy, after strenuous exercise, and in response to corticosteroids. When the white count is extremely elevated — tens or hundreds of times normal — leukaemia must be considered and a peripheral blood film examined urgently.

A low white count — leucopaenia — indicates reduced immune defence capacity. It occurs in viral infections including dengue fever — where it is a characteristic finding — and in bone marrow suppression from chemotherapy, certain medications, aplastic anaemia, and bone marrow infiltration by malignancy. Severe leucopaenia places patients at high risk of life-threatening infection from organisms that a normal immune system handles without difficulty.

---

The Differential White Count — Five Cell Types, Five Diagnostic Windows

The white cell differential breaks the total white count into its five constituent cell types — each with a distinct immune function and a distinct diagnostic significance when abnormal.

Neutrophils are the most numerous white cells in adults and the primary responders to bacterial infection. Neutrophilia — elevated neutrophils — occurs in bacterial infection, inflammation, corticosteroid use, and physiological stress. Neutropaenia — low neutrophils — is the most clinically significant leucopaenia, dramatically increasing infection risk.

Lymphocytes are the primary mediators of antiviral immunity and the cells responsible for antibody production. Lymphocytosis occurs in viral infections — particularly infectious mononucleosis and viral hepatitis — and is characteristically seen in chronic lymphocytic leukaemia, the most common adult leukaemia. Lymphopaenia occurs in HIV infection, corticosteroid use, and severe sepsis.

Monocytes are large phagocytic cells that rise in chronic infections including tuberculosis — an extremely common cause of monocytosis in Lahore — and in certain haematological malignancies including chronic myelomonocytic leukaemia.

Eosinophils are elevated — eosinophilia — in allergic conditions, asthma, and parasitic infections. In Pakistan, where intestinal parasites remain prevalent, eosinophilia on the CBC frequently prompts investigation for helminthic infection. Marked eosinophilia can also indicate eosinophilic disorders and certain malignancies.

Basophils are the least numerous white cells and least commonly the focus of clinical attention. Basophilia — elevated basophils — occurs in myeloproliferative disorders and allergic conditions and is one of the characteristic features of chronic myeloid leukaemia.

---

Platelet Count — Bleeding Risk and Beyond

The platelet count measures the number of platelets per litre of blood. Platelets form the initial plug at sites of vascular injury and are essential for haemostasis. Their count has direct implications for bleeding risk and for the diagnosis of several important conditions.

Thrombocytopaenia — a platelet count below the lower limit of normal — increases bleeding risk progressively as the count falls. At moderately low counts, patients may bruise easily and bleed more than expected from minor cuts. At severely low counts — below 20 to 30 × 10⁹ per litre — spontaneous bleeding into skin, mucous membranes, and in worst cases the brain becomes a genuine risk. Causes include immune thrombocytopaenia, dengue fever, chemotherapy, aplastic anaemia, hypersplenism, and disseminated intravascular coagulation.

Thrombocytosis — elevated platelets — occurs reactively in iron deficiency, infection, inflammation, and after splenectomy — all conditions extremely common in Pakistan’s patient population. Primary thrombocytosis from a myeloproliferative disorder such as essential thrombocythaemia requires evaluation when reactive causes are excluded.

---

Mean Platelet Volume — The Size of Platelets Matters

The mean platelet volume — MPV — measures the average size of platelets. Young, freshly produced platelets are larger than older ones. An elevated MPV with thrombocytopaenia suggests the bone marrow is actively producing platelets in response to peripheral destruction — as in immune thrombocytopaenia — because it is releasing large young platelets rapidly. A low MPV with thrombocytopaenia suggests impaired platelet production — as in aplastic anaemia or chemotherapy suppression — where the marrow cannot produce even normal-sized platelets in adequate numbers.

---

Haematology Laboratory at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, our haematology laboratory provides complete blood count analysis using modern automated analysers with expert manual review of abnormal samples. Every CBC is processed with the analytical precision and clinical relevance that sound diagnostic decision-making requires. Our experienced laboratory team and prompt reporting turnaround support clinicians across the city in delivering timely, accurate patient care.

What Is Haematology and Why Is It Central to Disease Diagnosis?

The Science of Blood — And Everything It Reveals

Of all the diagnostic investigations available in modern medicine, the blood test is the most universally used, the most information-rich, and the most fundamental. Before any other investigation is ordered, before any diagnosis is confirmed, before any treatment is planned — the blood is examined. And the medical specialty responsible for understanding, interpreting, and managing everything that blood reveals is haematology.

Haematology is the branch of medicine concerned with the study of blood — its components, its production, its function, and the diseases that affect it. It encompasses the diagnosis and management of anaemia, bleeding disorders, clotting abnormalities, bone marrow diseases, and blood cancers. It also underpins the interpretation of the complete blood count — the single most commonly ordered laboratory test in clinical medicine — that guides clinical decision-making across every medical specialty from general practice to oncology.

At Alnoor Diagnostic Centre in Shadman, Lahore, our haematology laboratory provides the comprehensive blood analysis that clinicians across the city depend on for accurate diagnosis and effective patient management.

---

What Blood Actually Contains — The Foundation of Haematological Understanding

Blood is a complex, living tissue comprising four main components suspended in a fluid called plasma. Red blood cells carry oxygen from the lungs to every tissue in the body and return carbon dioxide for exhalation. White blood cells form the cellular arm of the immune system, defending against bacterial, viral, fungal, and parasitic infection through multiple overlapping mechanisms. Platelets are the tiny cell fragments responsible for initiating clot formation at sites of vascular injury, preventing bleeding. Plasma — the pale yellow liquid in which all these cells are suspended — carries clotting proteins, nutrients, hormones, antibodies, and waste products throughout the circulation.

Each of these components is produced in the bone marrow — the spongy tissue filling the cavities of flat and long bones — through a continuous process called haematopoiesis. Stem cells within the bone marrow differentiate into the full range of blood cell types in response to growth factors and physiological signals. The entire circulating blood volume is completely renewed over weeks to months as older cells reach the end of their lifespan and new ones replace them.

When anything goes wrong with this production system — or with the function, survival, or regulation of the cells it produces — haematological disease results, and the blood test is the window through which it is identified.

---

The Complete Blood Count — The Most Important Haematological Investigation

The complete blood count — CBC — is the cornerstone of haematological diagnosis and one of the most information-dense investigations in all of clinical medicine. It measures the number, size, and in some cases the morphology of red blood cells, white blood cells, and platelets in a sample of blood — providing a quantitative snapshot of the entire cellular composition of the circulation.

The haemoglobin concentration tells the clinician immediately whether the patient is anaemic and how severely. The mean corpuscular volume — the average size of red blood cells — provides critical diagnostic discrimination between iron deficiency anaemia, where cells are small, vitamin B12 or folate deficiency anaemia, where cells are large, and anaemia of chronic disease, where cells may be normal in size. The red cell distribution width reflects the variability in red cell size — elevated in early iron deficiency and mixed deficiency states.

The white cell count and differential — the breakdown of total white cells into their constituent types — reveals whether the immune system is responding to bacterial infection, viral infection, allergic disease, or parasitic infestation, and whether white cell production in the bone marrow is normal or abnormal. A markedly elevated white count with a predominance of immature cells raises immediate concern for leukaemia. A severely depressed white count signals immunosuppression from medication, bone marrow failure, or overwhelming infection. The platelet count screens for thrombocytopaenia — the platelet deficiency that increases bleeding risk — and thrombocytosis, which can indicate inflammation, iron deficiency, or a myeloproliferative disorder.

No other single investigation delivers this breadth of diagnostic information from a few millilitres of blood in a matter of minutes.

---

Peripheral Blood Film — Looking Beyond the Numbers

While the automated CBC provides quantitative data with speed and precision, the peripheral blood film — a thin smear of blood examined under a microscope by a trained haematologist or laboratory scientist — adds qualitative information that no automated analyser can replicate. Abnormal cell shapes, inclusions within cells, immature cell forms, and the presence of parasites are all identified on the peripheral blood film in ways that change diagnoses and direct treatment.

Sickle cells — the abnormally shaped red cells of sickle cell disease — are unmistakable on a peripheral film. Target cells appear in liver disease, thalassaemia, and iron deficiency. Hypersegmented neutrophils signal megaloblastic anaemia from B12 or folate deficiency. Blast cells — immature marrow cells that should not be circulating — appear in leukaemia. Malarial parasites within red cells are visible directly on a well-prepared film examined by an experienced eye.

The peripheral blood film is a diagnostic tool of remarkable sensitivity and specificity when interpreted by someone with haematological expertise — and it remains irreplaceable despite the sophistication of modern automated haematology analysers.

---

Haematology in the Diagnosis of Non-Haematological Disease

The importance of haematology extends far beyond the diagnosis of blood-specific diseases. Changes in blood composition are among the earliest and most sensitive indicators of disease in virtually every organ system and every medical specialty.

Anaemia is one of the most common findings in chronic disease across all specialties — chronic kidney disease, inflammatory bowel disease, rheumatoid arthritis, heart failure, malignancy, and chronic infection all produce characteristic anaemia patterns that haematological investigation identifies and characterises. In the context of kidney disease, haematology tracks the erythropoietin-deficiency anaemia that requires treatment alongside the primary renal condition.

Infection and inflammation — from pneumonia, urinary tract infection, tuberculosis, dengue fever, typhoid, and sepsis — all produce characteristic white cell responses that haematological investigation identifies rapidly, guiding antibiotic selection and monitoring treatment response. Dengue fever’s characteristic thrombocytopaenia and leucopaenia are haematological findings that support the clinical diagnosis before serology results are available.

Liver disease, malnutrition, and malabsorption are all reflected in haematological parameters — macrocytic anaemia from folate and B12 deficiency, coagulopathy from impaired clotting factor synthesis, and thrombocytopaenia from hypersplenism are all haematological consequences of hepatic disease. Bone marrow infiltration by solid tumour metastases produces a characteristic leukoerythroblastic blood picture that haematological examination identifies, indicating marrow involvement before imaging may be available.

---

Coagulation Testing — Understanding Bleeding and Clotting

Alongside the CBC, coagulation studies form the second pillar of haematological laboratory investigation. The prothrombin time — PT — and activated partial thromboplastin time — APTT — assess the integrity of the clotting cascade, identifying deficiencies of clotting factors from liver disease, vitamin K deficiency, warfarin therapy, haemophilia, and von Willebrand disease. The international normalised ratio — INR — derived from the PT — is the standard measure for monitoring warfarin anticoagulation therapy and for assessing liver synthetic function.

Fibrinogen measurement, d-dimer testing for thromboembolic disease, and specific factor assays for individual clotting factor deficiencies complete the coagulation testing repertoire that haematology provides. These investigations guide decisions about blood product use in surgical and obstetric haemorrhage, confirm the diagnosis of inherited bleeding disorders, and monitor anticoagulation therapy across thousands of patients in Lahore every day.

---

Haematology Laboratory at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, our haematology laboratory provides the complete range of blood count, peripheral film examination, coagulation, and specialist haematological investigations that clinicians across the city depend on. Our experienced laboratory team operates modern automated analysers with expert manual review and delivers results with the accuracy and turnaround time that clinical decision-making demands.